SBC Medical Group Holdings Incorporated cash flow statement SBC

Annual Quarterly

In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, SBC Medical Group Holdings Incorporated generated $22.5 million of cash from operations, up 369.9% from the same quarter a year earlier. It spent $84,396 on capital expenditures. That left free cash flow of $22.4 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

TTM
Jun 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Operating
Depreciation and amortization
3
1
+78.0%
1
+6.7%
1
-27.7%
1
-74.0%
1
1
1
3
Stock-based compensation
—
0
—
0
-100.0%
0
-100.0%
—
—
0
13
Operating cash flow
63
+821.8%
23
+369.9%
9
+378.7%
52
+811.5%
-21
-516.7%
-8
-143.5%
2
-47.6%
-7
-126.2%
5
-79.2%
Investing
Capital expenditures
1
0
-72.5%
0
-50.7%
1
+35.1%
0
-97.8%
0
0
1
2
Investing cash flow
-36
-347.1%
1
-96.5%
-1
+46.1%
-24
-432.3%
-12
-415.7%
16
+372.4%
-1
+71.2%
-5
+33.8%
4
+104.2%
Financing
Stock buybacks
3
0
-100.0%
—
0
3
2
—
—
—
Financing cash flow
28
-8.0%
-2
-127.3%
-2
-557.1%
20
+74.2%
12
-1.1%
7
+10491.7%
-0
-597.0%
11
+9046.1%
12
-88.9%
Change in cash
Net change in cash
32
17
-17.8%
4
-49.6%
36
+394.3%
-25
-173.6%
21
7
+202.5%
-12
-148.3%
34
+36.4%
Free cash flow
62
22
+359.4%
9
+443.7%
51
+748.2%
-21
-789.0%
-9
2
-8
3
Per share
Free cash flow per share
0.60
0.22
+361.7%
0.09
+447.4%
0.50
+748.9%
-0.20
-738.4%
-0.08
0.02
-0.08
0.03
Shareholder returns
Returned to shareholders
3
0
—
0
3
2
—
—
—
Share of free cash flow
4.18%
0.00%
—
0.00%
—
—
—
—
—
Ratios
Free cash flow margin
35.26%
45.59%
21.15%
129.32%
-48.27%
-19.94%
3.54%
-17.77%
5.72%
Capital expenditures to revenue
0.60%
0.17%
0.29%
2.02%
0.10%
0.71%
0.54%
1.33%
3.72%
Stock-based compensation to revenue
—
0.02%
—
0.00%
0.00%
—
—
0.48%
24.13%
Cash conversion
1.28x
2.11x
0.82x
3.66x
-1.63x
-3.39x
0.09x
-1.12x
1.77x
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
SBC (Nasdaq), SBCWW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1930313
Former names
Pono Capital Two, Inc. (until Aug 29, 2024)

Other Services-Offices & Clinics of Doctors of Medicine companies

All 12 Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.